You are here:

Bemiparin, 2500 IU in 0.2 ml and 3500 IU in 0.2 ml, injection for sub-cutaneous administration (Zibor®)

Advice

Following a full submission

Bemiparin (Zibor) is not recommended for use within NHS Scotland for the prevention of clotting in the extracorporeal circuit during haemodialysis.

It showed similar efficacy to unfractionated heparin in preventing coagulation in the extracorporeal circuit but has not been compared with other low molecular weight heparins.

No evidence of the cost effectiveness of bemiparin during haemodialysis has been presented by the manufacturer.

Drug Details

Drug Name: Bemiparin, 2500 IU in 0.2 ml and 3500 IU in 0.2 ml, injection for sub-cutaneous administration (Zibor®)
SMC Drug ID: 205/05
Manufacturer: Amdipharm PLC
Indication: Prevention of clotting in extracorporeal circuit during haemodialysis
BNF Category:
Sub Category: 2.8 Anticoagulants and protamine
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 10 October 2005

Back